UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006183
Receipt number R000007242
Scientific Title Research of the utility of newly developed implant system (Octafix)
Date of disclosure of the study information 2011/08/17
Last modified on 2011/08/17 15:50:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research of the utility of newly developed implant system (Octafix)

Acronym

Research of dental implant system

Scientific Title

Research of the utility of newly developed implant system (Octafix)

Scientific Title:Acronym

Research of dental implant system

Region

Japan


Condition

Condition

missing tooth

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this research is to consider the clinical utility of Octafix implant, which is newly put on the market.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We will put an octa-fix implant into a place of missing tooth. We will follow for up to 5 years.

Evaluation and test items
<Treatment evaluation>
Success rate of implant therapy: whether or not the implant is functioning soundly.
Survival rate of implant therapy: whether or not the implant is remaining.

<Absorption rate of a peripheral bone>
We will take dental X-rays shortly after an implant is put into a bone, and the superstructure is fixed. Furthermore, we will take dental X-rays 12 months, 24 months, 36 months, (and 60 months) after the superstructure is fixed. Then, we will evaluate absorption rate of a peripheral bone with dental X-ray photos.

<Consideration of the period to osseointegration>
Only for specific patients.
We will use an implant-mobility indicator (Ostel ISQ). We will measure implant mobility shortly after an implant is put into a bone, and every 2 weeks for 16 weeks.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

We will put an Octafix implant into a place of missing tooth. We will follow for up to 5 years.

Evaluation and test items
<Treatment evaluation>
Success rate of implant therapy: whether or not the implant is functioning soundly.
Survival rate of implant therapy: whether or not the implant is remaining.

<Absorption rate of a peripheral bone>
We will take dental X-rays shortly after an implant is put into a bone, and the superstructure is fixed. Furthermore, we will take dental X-rays 12 months, 24 months, 36 months, (and 60 months) after the superstructure is fixed. Then, we will evaluate absorption rate of a peripheral bone with dental X-ray photos.

<Consideration of the period to osseointegration>
Only for specific patients.
We will use an implant-mobility indicator (Ostel ISQ). We will measure implant mobility shortly after an implant is put into a bone, and every 2 weeks for 16 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A patient that loses more than one tooth, desires implant therapy, and that the attending dentist considers is suitable for implant therapy.

1)Patient that can receive prosthesis therapy of fixed superstructure
2)Patient that understands the aim of this research, and cooperates for long periods of time

Key exclusion criteria

1) patient with immunodeficiency (a long course of antibiotics, use of steroid, use of immunosuppressive drug)
2) patient expected to bring on incomplete cure of bone(use of bisphosphonate, after radiation to head and neck area, etc.)
3) patient with severe metabolic disease or mal-controlled metabolic disease
4) patient with kidney failure
5) patient with contraindication to surgical management
6) parturient
7) patient whose oral hygiene is poor
8) patient that needs large-sized bone augmentation (except for GBR, small-sized bone graft to socket, etc.)
9) patient with mucosal disease on the place of implant therapy
10) patient with heavy bruxism
11) patient that the attending dentist considers is unsuitable for implant therapy

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name HIroshi Kurita

Organization

Shinsyu University School of Medicine

Division name

Department of Dentistry and Oral Surgery

Zip code


Address

3-1-1,Asahi,Matsumoto,Nagano

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Shinsyu University School of Medicine

Division name

Department of Dentistry and Oral Surgery

Zip code


Address


TEL

0263-37-2677

Homepage URL


Email



Sponsor or person

Institute

Department of Dentistry and Oral Surgery,Shinsyu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Yoshioka, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 08 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2011 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 08 Month 17 Day

Last modified on

2011 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007242


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name